Bassoy E, Raja R, Rubino Jr T, Coscia F, Goergen K, Magtibay P
Oncoimmunology. 2025; 14(1):2460276.
PMID: 39891409
PMC: 11792853.
DOI: 10.1080/2162402X.2025.2460276.
Tan T, Wu C, Wang R, Pan B, Hawke D, Yin F
iScience. 2025; 28(1):111603.
PMID: 39834856
PMC: 11743101.
DOI: 10.1016/j.isci.2024.111603.
Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N
Signal Transduct Target Ther. 2025; 10(1):11.
PMID: 39800748
PMC: 11734941.
DOI: 10.1038/s41392-024-02080-z.
Zhang H, Yu J, Yang Z, Guo Z, Liu R, Qin Q
RSC Med Chem. 2024; 15(9):3114-3124.
PMID: 39309356
PMC: 11411631.
DOI: 10.1039/d4md00389f.
Melia E, Parsons J
Cancers (Basel). 2024; 16(17).
PMID: 39272874
PMC: 11394570.
DOI: 10.3390/cancers16173016.
Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer.
Li M, Lulla A, Wang Y, Tsavaschidis S, Wang F, Karakas C
Cancer Res. 2024; 84(22):3864-3880.
PMID: 39186665
PMC: 11567801.
DOI: 10.1158/0008-5472.CAN-23-4130.
Cryo-EM structure of the CDK2-cyclin A-CDC25A complex.
Rowland R, Korolchuk S, Salamina M, Tatum N, Ault J, Hart S
Nat Commun. 2024; 15(1):6807.
PMID: 39122719
PMC: 11316097.
DOI: 10.1038/s41467-024-51135-w.
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer.
Chen A, Kim B, Mitra A, Vollert C, Lei J, Fandino D
Mol Cancer Ther. 2024; 23(10):1494-1510.
PMID: 38781103
PMC: 11443213.
DOI: 10.1158/1535-7163.MCT-23-0564.
Tryptophanyl-tRNA synthetase-1 (WARS-1) depletion and high tryptophan concentration lead to genomic instability in Caenorhabditis elegans.
Izadi M, Ali T, Shurrab F, Aharpour E, Pourkarimi E
Cell Death Discov. 2024; 10(1):165.
PMID: 38575580
PMC: 10995160.
DOI: 10.1038/s41420-024-01917-4.
FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe.
OBrien S, Ubhi T, Wolf L, Gandhi K, Lin S, Chaudary N
Cancer Res Commun. 2023; 3(12):2596-2607.
PMID: 38032106
PMC: 10734389.
DOI: 10.1158/2767-9764.CRC-23-0306.
Myt1 overexpression mediates resistance to cell cycle and DNA damage checkpoint kinase inhibitors.
Sokhi S, Lewis C, Bukhari A, Hadfield J, Xiao E, Fung J
Front Cell Dev Biol. 2023; 11:1270542.
PMID: 38020882
PMC: 10652759.
DOI: 10.3389/fcell.2023.1270542.
SARS-CoV-2 and the DNA damage response.
Grand R
J Gen Virol. 2023; 104(11).
PMID: 37948194
PMC: 10768691.
DOI: 10.1099/jgv.0.001918.
CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination.
Brown V, Moore S, Chen M, House N, Ramsden P, Wu H
NAR Cancer. 2023; 5(3):zcad039.
PMID: 37519629
PMC: 10373114.
DOI: 10.1093/narcan/zcad039.
Cyclers' kinases in cell division: from molecules to cancer therapy.
Milletti G, Colicchia V, Cecconi F
Cell Death Differ. 2023; 30(9):2035-2052.
PMID: 37516809
PMC: 10482880.
DOI: 10.1038/s41418-023-01196-z.
The SUMO-NIP45 pathway processes toxic DNA catenanes to prevent mitotic failure.
Hertz E, Vega I, Kruse T, Wang Y, Hendriks I, Bizard A
Nat Struct Mol Biol. 2023; 30(9):1303-1313.
PMID: 37474739
PMC: 10497417.
DOI: 10.1038/s41594-023-01045-0.
Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders.
Alli V, Yadav P, Suresh V, Jadav S
ACS Omega. 2023; 8(23):20196-20233.
PMID: 37323408
PMC: 10268025.
DOI: 10.1021/acsomega.3c01558.
BrcaDx: precise identification of breast cancer from expression data using a minimal set of features.
Muthamilselvan S, Palaniappan A
Front Bioinform. 2023; 3:1103493.
PMID: 37287543
PMC: 10242386.
DOI: 10.3389/fbinf.2023.1103493.
Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer.
Du X, Yang X, Wang Q, Lin G, Li P, Zhang W
Heliyon. 2023; 9(2):e13185.
PMID: 36747547
PMC: 9898304.
DOI: 10.1016/j.heliyon.2023.e13185.
APC/CCDC20 targets SCFFBL17 to activate replication stress responses in Arabidopsis.
Pan T, Gao S, Cui X, Wang L, Yan S
Plant Cell. 2022; 35(2):910-923.
PMID: 36503931
PMC: 9940874.
DOI: 10.1093/plcell/koac360.
A mechanical G2 checkpoint controls epithelial cell division through E-cadherin-mediated regulation of Wee1-Cdk1.
Donker L, Houtekamer R, Vliem M, Sipieter F, Canever H, Gomez-Gonzalez M
Cell Rep. 2022; 41(2):111475.
PMID: 36223752
PMC: 7617330.
DOI: 10.1016/j.celrep.2022.111475.